1don MSN
Genetic screening technique could enhance CAR-T therapies for multiple myeloma and other cancers
Researchers from Mass General Brigham and the Broad Institute of MIT and Harvard have identified genetic modifications that ...
CAR T cells are patient-derived, genetically engineered immune cells. They are "living drugs" and constitute a milestone in ...
A new study published in JCO Precision Oncology has identified a relatively simple method to predict the cancer patients most likely to develop severe toxicities from chemotherapy. If doctors can ...
PacBio enters the high-throughput carrier screening market with a standalone HiFi sequencing assay for challenging genes.
A little over a year into the Sanford ImagineYou study, patients are reporting positive results in detecting early risk factors.
David Godler is the group leader of the diagnosis and development laboratory at the Murdoch Children’s Research Institute ...
Please provide your email address to receive an email when new articles are posted on . Digital screening improved identification of patients meeting hereditary risk assessment guidelines. Patient ...
News Medical on MSN
Family Heart Foundation announces recommendations to improve universal screening for underdiagnosed genetic condition in children, which causes early ons…
The Family Heart Foundation, a leading research and advocacy organization, announced the online publication of ...
Routine genetic testing for maturity-onset diabetes of the young (MODY) could be cost-effective or even save money, depending on the price of the test and the prevalence of MODY in the population ...
6hon MSN
Uncovering genetic factors in radiotherapy side effects: Dr Samantha Cairncross's PhD thesis
Dr Samantha Cairncross's lifelong fascination with science has culminated in a revolutionary PhD thesis, revealing genetic ...
LONDON, United Kingdom — Newly identified genetic variants could revolutionize cancer screening by distinguishing people at highest risk for certain cancers from people at lowest risk. The largest ...
Bupa has introduced a pharmacogenomics testing program for its health insurance customers in Australia, making genetic screening available to eligible members at no cost until the end of 2025.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results